Carla S. Veríssimo

Targeting mutant RAS in patient-derived colorectal cancer organoids by combinatorial drug screening

Carla S. Veríssimo, René Overmeer, Bas Ponsioen et al. · eLife · 2016 · 270 citations · Full text

Medicine, Cancer Biology, Oncology +17

Long-term culture, genetic manipulation and xenotransplantation of human normal and breast cancer organoids

Johanna F. Dekkers, Esmée J. van Vliet, Norman Sachs et al. · Nature Protocols · 2021 · 265 citations · Full text

Medicine, Cancer Biology, Oncology +15

MicroRNA 18 and 124a Down-Regulate the Glucocorticoid Receptor: Implications for Glucocorticoid Responsiveness in the Brain

Erno Vreugdenhil, Carla S. Veríssimo, Rob Mariman et al. · Endocrinology · 2009 · 259 citations · Full text

Life Sciences, Molecular Biology, Neuroscience +17

Doublecortin and doublecortin‐like are expressed in overlapping and non‐overlapping neuronal cell population: Implications for neurogenesis

Dirk‐Jan Saaltink, Bjarte Håvik, Carla S. Veríssimo et al. · The Journal of Comparative Neurology · 2012 · 73 citations

Life Sciences, Neurobiology, Neuroscience +17

Drug-repurposing screen on patient-derived organoids identifies therapy-induced vulnerability in KRAS-mutant colon cancer

Sander Mertens, Maarten A. Huismans, Carla S. Veríssimo et al. · Cell Reports · 2023 · 69 citations · Full text

Medicine, Oncology, Pharmacology +15